Thomas Pressly, MD | |
2751 Albert L Bicknell Dr, Suite 2e, Shreveport, LA 71103-3920 | |
(318) 635-5682 | |
Not Available |
Full Name | Thomas Pressly |
---|---|
Gender | Male |
Speciality | Rheumatology |
Experience | 36 Years |
Location | 2751 Albert L Bicknell Dr, Shreveport, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588779425 | NPI | - | NPPES |
92332 | Other | LA | HEALTH ADVANTAGE |
92332 | Other | AR | BLUE CROSS OF AR |
0097TU | Other | TX | BLUE CROSS TX |
416766 | Other | LA | COVENTRY OF LOUISIANA |
1381497 | Medicaid | LA | |
SH7303 | Other | LA | UNITED HEALTHCARE OF LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | 007744R (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Willis Knighton Medical Center, Inc | Shreveport, LA | Hospital |
Christus St Michael Health System | Texarkana, TX | Hospital |
Wadley Regional Medical Center | Texarkana, TX | Hospital |
Desoto Regional Health System | Mansfield, LA | Hospital |
Entity Name | Thomas A Pressly Iii Apmc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205012291 PECOS PAC ID: 6507941531 Enrollment ID: O20080314000100 |
News Archive
The trefoil factor 3 (TFF3) protein protects and maintains the integrity of the epithelial surface in the normal breast. New research has found that while TFF3 protein expression is higher in well-differentiated low grade tumors and therefore associated with features of a good prognosis, it has a more sinister role in breast cancer invasion and metastasis.
Omega Healthcare Investors, Inc. announced today its intention to offer $400 million aggregate principal amount of its senior notes due 2024 in a private placement, subject to market and other conditions.
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS).
Recognized for their pioneering work in the development of gene transfer technology using retroviral vectors to deliver therapeutic genes into cells, Richard C. Mulligan, PhD, Director of the Harvard Gene Therapy Initiative, Harvard Institutes of Medicine, Boston, MA, and A. Dusty Miller, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, received the Pioneer Award from Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 7 days ago
Entity Name | Shriners Hospitals For Children |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1679617849 PECOS PAC ID: 9133031933 Enrollment ID: O20121203000457 |
News Archive
The trefoil factor 3 (TFF3) protein protects and maintains the integrity of the epithelial surface in the normal breast. New research has found that while TFF3 protein expression is higher in well-differentiated low grade tumors and therefore associated with features of a good prognosis, it has a more sinister role in breast cancer invasion and metastasis.
Omega Healthcare Investors, Inc. announced today its intention to offer $400 million aggregate principal amount of its senior notes due 2024 in a private placement, subject to market and other conditions.
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS).
Recognized for their pioneering work in the development of gene transfer technology using retroviral vectors to deliver therapeutic genes into cells, Richard C. Mulligan, PhD, Director of the Harvard Gene Therapy Initiative, Harvard Institutes of Medicine, Boston, MA, and A. Dusty Miller, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, received the Pioneer Award from Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Thomas Pressly, MD 2751 Albert L Bicknell Dr, Suite 2e, Shreveport, LA 71103-3920 Ph: (318) 635-5682 | Thomas Pressly, MD 2751 Albert L Bicknell Dr, Suite 2e, Shreveport, LA 71103-3920 Ph: (318) 635-5682 |
News Archive
The trefoil factor 3 (TFF3) protein protects and maintains the integrity of the epithelial surface in the normal breast. New research has found that while TFF3 protein expression is higher in well-differentiated low grade tumors and therefore associated with features of a good prognosis, it has a more sinister role in breast cancer invasion and metastasis.
Omega Healthcare Investors, Inc. announced today its intention to offer $400 million aggregate principal amount of its senior notes due 2024 in a private placement, subject to market and other conditions.
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS).
Recognized for their pioneering work in the development of gene transfer technology using retroviral vectors to deliver therapeutic genes into cells, Richard C. Mulligan, PhD, Director of the Harvard Gene Therapy Initiative, Harvard Institutes of Medicine, Boston, MA, and A. Dusty Miller, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, received the Pioneer Award from Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 7 days ago
Mansi Shah, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1455 E Bert Koun Loop, #210, Shreveport, LA 71105 Phone: 318-798-4515 Fax: 318-798-4530 | |
Pratik Agrawal, Rheumatology Medicare: Medicare Enrolled Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 | |
Dr. Bader Alotaibi, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 2727 Hearne Ave Ste 301, Shreveport, LA 71103 Phone: 318-631-6400 | |
Paul A Rushing, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1455 E Bert Kouns Loop, Shreveport, LA 71105 Phone: 318-798-4488 Fax: 318-798-4420 | |
Sanjay Jain, Rheumatology Medicare: Medicare Enrolled Practice Location: 510 E Stoner Ave, Primary Care (110), Shreveport, LA 71101 Phone: 318-221-8411 | |
Steven R Bailey, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 | |
Venkateswara K Rao, M.D., Rheumatology Medicare: Medicare Enrolled Practice Location: 1501 Kings Hwy, Department Of Medicine, Shreveport, LA 71103 Phone: 318-675-5000 |